Skip to content
  • Tuesday, 27 October 2026
  • 11:28 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Unlocking the Molecular Clock: Duke-NUS Researchers Discover Protein Balance Critical to Combating Age-Related Muscle Loss and Cachexia
Stem Cell & Regenerative Medicine

Unlocking the Molecular Clock: Duke-NUS Researchers Discover Protein Balance Critical to Combating Age-Related Muscle Loss and Cachexia

Dwi Wanna Oct 7, 2026 0

As life expectancies climb globally, public health systems face an unprecedented demographic shift. Populations are aging rapidly, and with this…

Read More
Stem Cell & Regenerative Medicine

Breakthrough Discovery at Duke-NUS Medical School Unveils Molecular Key to Combating Age-Related Muscle Wasting and Sarcopenia

Dwi Wanna Sep 17, 2026 0

As global demographics shift toward an increasingly older population, public health systems face mounting pressure to address age-associated degenerative conditions.…

Read More
Stem Cell & Regenerative Medicine

Duke-NUS Researchers Identify DEAF1 Protein as Key Regulator in Muscle Regeneration and Treatment for Sarcopenia and Cachexia

Dwi Wanna May 30, 2026 0

In an era defined by a rapidly aging global population, the medical community is facing an unprecedented rise in age-related…

Read More
Stem Cell & Regenerative Medicine

Duke-NUS Researchers Discover Molecular Switch Regulating Muscle Regeneration and Sarcopenia

Dwi Wanna May 8, 2026 0

The global demographic shift toward an ageing population has brought age-related health conditions to the forefront of medical research, with…

Read More
Stem Cell & Regenerative Medicine

Duke-NUS Medical School Scientists Discover DEAF1 Protein Mechanism as Key to Reversing Muscle Loss in Sarcopenia and Cancer Cachexia

Dwi Wanna Mar 24, 2026 0

As the global population undergoes a profound demographic shift toward an older age profile, the prevalence of age-related physical decline…

Read More
Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfrontDecoding the Genetic Secrets of Longevity and Immune Resilience in Bat GenomesJapanese Researchers Identify Key Protein Interaction Regulating Sperm Development and Male FertilityA common vape flavoring may disrupt early embryo development
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ